Multiple umbilical cord–derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis

Background/objectives: Articular cartilage erosion probably plays a substantial role in osteoarthritis (OA) initiation and development. Studies demonstrated that umbilical cord–derived mesenchymal stem cells (UCMSCs) could delay chondrocytes apoptosis and ameliorate OA progression in patients, but t...

Full description

Bibliographic Details
Main Authors: Wei Tong, Xiaoguang Zhang, Quan Zhang, Jiarui Fang, Yong Liu, Zengwu Shao, Shuhua Yang, Dongcheng Wu, Xiaoming Sheng, Yingze Zhang, Hongtao Tian
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:Journal of Orthopaedic Translation
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214031X20300371
_version_ 1818291600746348544
author Wei Tong
Xiaoguang Zhang
Quan Zhang
Jiarui Fang
Yong Liu
Zengwu Shao
Shuhua Yang
Dongcheng Wu
Xiaoming Sheng
Yingze Zhang
Hongtao Tian
author_facet Wei Tong
Xiaoguang Zhang
Quan Zhang
Jiarui Fang
Yong Liu
Zengwu Shao
Shuhua Yang
Dongcheng Wu
Xiaoming Sheng
Yingze Zhang
Hongtao Tian
author_sort Wei Tong
collection DOAJ
description Background/objectives: Articular cartilage erosion probably plays a substantial role in osteoarthritis (OA) initiation and development. Studies demonstrated that umbilical cord–derived mesenchymal stem cells (UCMSCs) could delay chondrocytes apoptosis and ameliorate OA progression in patients, but the detailed mechanisms are largely uncharacterised. In this study, we aimed to study the effects of UCMSCs on monosodium iodoacetate (MIA)–induced rat OA model, and explore the cellular mechanism of this effect. Methods: Intra-articular injection of 0.3 ​mg MIA in 50 ​μL saline was performed on the left knee of the 200 ​g weight male Sprague-Dawley rat to induce rat knee OA. A single dose of 2.5 ​× ​105 undifferentiated UCMSCs one day after MIA or three-time intra-articular injection of 2.5 ​× ​105 UCMSCs on Days 1, 7 ​and 14 were given, respectively. Four weeks after MIA, joints were harvested and processed for paraffin sections. Safranine-O staining, haematoxylin and eosin staining ​and immunohistochemistry of MMP-13, ADAMTS-5, Col-2, CD68 ​and CD4 were performed to observe cartilage erosion and synovium. For in vitro ​studies, migration ability of cartilage superficial layer cells (SFCs) by UCMSCs were accessed by transwell assay. Furthermore, catabolism change of MIA-induced SFCs by UCMSCs was performed by real-rime polymerase chain reaction of Col-X and BCL-2 genes. CCK-8 assay was performed to check proliferation ability of SFCs by UCMSCs-conditioned media. Result: In this study, we locally injected human UCMSCs, which is highly proliferative and noninvasively collectible, into MIA-induced rat knee OA. An important finding is on obviously ameliorated cartilage erosion and decreased OA Mankin score by repeated UCMSCs injection after MIA injection compared with single injection, both of which attenuated OA progression compared with vehicle. Interestingly, we observed significantly increased number of SFCs on the articular cartilage surface, probably related to elevated proliferation, mobilisation and inhibited catabolism marker: Col-X and BCL-2 gene expression of cultured SFCs by UCMSCs-conditioned media treatment in vitro. In addition to the change of unique SFCs, catabolism markers of ADAMTS-5 and MMP-13 were substantially upregulated in the whole cartilage layer chondrocytes as well. Strikingly, MIA-induced inflammatory cells infiltration, on both CD4+ Th cells and CD68+ macrophages, and hyperplasia of the synovium, which was alleviated by repeated UCMSCs injection. Conclusion: Our study demonstrated a critical role of repeated UCMSCs dosing on preserving SFCs function, cartilage structure and inhibiting synovitis during OA progression, and thus provided mechanistic proof of evidence for the use of UCMSCs on OA patients in the future. The translational potential of this article: UCMSCs are a relatively “young” stem cell, and noninvasively collectible. In our study, we clearly demonstrated that it could effectively delay OA progression, possibly through reserving SFCs function and inhibiting synovitis. Therefore, it could be a new promising therapeutic cell source for OA after further clinical trials.
first_indexed 2024-12-13T02:46:39Z
format Article
id doaj.art-444efbf01644442ca0ff3ddbc89611f2
institution Directory Open Access Journal
issn 2214-031X
language English
last_indexed 2024-12-13T02:46:39Z
publishDate 2020-07-01
publisher Elsevier
record_format Article
series Journal of Orthopaedic Translation
spelling doaj.art-444efbf01644442ca0ff3ddbc89611f22022-12-22T00:02:10ZengElsevierJournal of Orthopaedic Translation2214-031X2020-07-01232128Multiple umbilical cord–derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitisWei Tong0Xiaoguang Zhang1Quan Zhang2Jiarui Fang3Yong Liu4Zengwu Shao5Shuhua Yang6Dongcheng Wu7Xiaoming Sheng8Yingze Zhang9Hongtao Tian10Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, ChinaDepartment of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, ChinaWuhan Hamilton Biotechnology Co., Ltd., Wuhan, 430075, Hubei, ChinaDepartment of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, ChinaDepartment of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, ChinaDepartment of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, ChinaDepartment of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, ChinaWuhan Hamilton Biotechnology Co., Ltd., Wuhan, 430075, Hubei, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430072, Hubei, ChinaApplied Statistics, University of Utah College of Nursing, 10 South 2000 East, Salt Lake City, UT, 84112, USAThe Third Hospital of Hebei Medical University, Shijiazhuang, 050051, Hebei, ChinaDepartment of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China; Corresponding author. Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.Background/objectives: Articular cartilage erosion probably plays a substantial role in osteoarthritis (OA) initiation and development. Studies demonstrated that umbilical cord–derived mesenchymal stem cells (UCMSCs) could delay chondrocytes apoptosis and ameliorate OA progression in patients, but the detailed mechanisms are largely uncharacterised. In this study, we aimed to study the effects of UCMSCs on monosodium iodoacetate (MIA)–induced rat OA model, and explore the cellular mechanism of this effect. Methods: Intra-articular injection of 0.3 ​mg MIA in 50 ​μL saline was performed on the left knee of the 200 ​g weight male Sprague-Dawley rat to induce rat knee OA. A single dose of 2.5 ​× ​105 undifferentiated UCMSCs one day after MIA or three-time intra-articular injection of 2.5 ​× ​105 UCMSCs on Days 1, 7 ​and 14 were given, respectively. Four weeks after MIA, joints were harvested and processed for paraffin sections. Safranine-O staining, haematoxylin and eosin staining ​and immunohistochemistry of MMP-13, ADAMTS-5, Col-2, CD68 ​and CD4 were performed to observe cartilage erosion and synovium. For in vitro ​studies, migration ability of cartilage superficial layer cells (SFCs) by UCMSCs were accessed by transwell assay. Furthermore, catabolism change of MIA-induced SFCs by UCMSCs was performed by real-rime polymerase chain reaction of Col-X and BCL-2 genes. CCK-8 assay was performed to check proliferation ability of SFCs by UCMSCs-conditioned media. Result: In this study, we locally injected human UCMSCs, which is highly proliferative and noninvasively collectible, into MIA-induced rat knee OA. An important finding is on obviously ameliorated cartilage erosion and decreased OA Mankin score by repeated UCMSCs injection after MIA injection compared with single injection, both of which attenuated OA progression compared with vehicle. Interestingly, we observed significantly increased number of SFCs on the articular cartilage surface, probably related to elevated proliferation, mobilisation and inhibited catabolism marker: Col-X and BCL-2 gene expression of cultured SFCs by UCMSCs-conditioned media treatment in vitro. In addition to the change of unique SFCs, catabolism markers of ADAMTS-5 and MMP-13 were substantially upregulated in the whole cartilage layer chondrocytes as well. Strikingly, MIA-induced inflammatory cells infiltration, on both CD4+ Th cells and CD68+ macrophages, and hyperplasia of the synovium, which was alleviated by repeated UCMSCs injection. Conclusion: Our study demonstrated a critical role of repeated UCMSCs dosing on preserving SFCs function, cartilage structure and inhibiting synovitis during OA progression, and thus provided mechanistic proof of evidence for the use of UCMSCs on OA patients in the future. The translational potential of this article: UCMSCs are a relatively “young” stem cell, and noninvasively collectible. In our study, we clearly demonstrated that it could effectively delay OA progression, possibly through reserving SFCs function and inhibiting synovitis. Therefore, it could be a new promising therapeutic cell source for OA after further clinical trials.http://www.sciencedirect.com/science/article/pii/S2214031X20300371Cartilage superficial layer cellsChondrocyteOsteoarthritisSynovitisUmbilical cord–derived mesenchymal stem cells
spellingShingle Wei Tong
Xiaoguang Zhang
Quan Zhang
Jiarui Fang
Yong Liu
Zengwu Shao
Shuhua Yang
Dongcheng Wu
Xiaoming Sheng
Yingze Zhang
Hongtao Tian
Multiple umbilical cord–derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis
Journal of Orthopaedic Translation
Cartilage superficial layer cells
Chondrocyte
Osteoarthritis
Synovitis
Umbilical cord–derived mesenchymal stem cells
title Multiple umbilical cord–derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis
title_full Multiple umbilical cord–derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis
title_fullStr Multiple umbilical cord–derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis
title_full_unstemmed Multiple umbilical cord–derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis
title_short Multiple umbilical cord–derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis
title_sort multiple umbilical cord derived mscs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis
topic Cartilage superficial layer cells
Chondrocyte
Osteoarthritis
Synovitis
Umbilical cord–derived mesenchymal stem cells
url http://www.sciencedirect.com/science/article/pii/S2214031X20300371
work_keys_str_mv AT weitong multipleumbilicalcordderivedmscsadministrationsattenuateratosteoarthritisprogressionviapreservingarticularcartilagesuperficiallayercellsandinhibitingsynovitis
AT xiaoguangzhang multipleumbilicalcordderivedmscsadministrationsattenuateratosteoarthritisprogressionviapreservingarticularcartilagesuperficiallayercellsandinhibitingsynovitis
AT quanzhang multipleumbilicalcordderivedmscsadministrationsattenuateratosteoarthritisprogressionviapreservingarticularcartilagesuperficiallayercellsandinhibitingsynovitis
AT jiaruifang multipleumbilicalcordderivedmscsadministrationsattenuateratosteoarthritisprogressionviapreservingarticularcartilagesuperficiallayercellsandinhibitingsynovitis
AT yongliu multipleumbilicalcordderivedmscsadministrationsattenuateratosteoarthritisprogressionviapreservingarticularcartilagesuperficiallayercellsandinhibitingsynovitis
AT zengwushao multipleumbilicalcordderivedmscsadministrationsattenuateratosteoarthritisprogressionviapreservingarticularcartilagesuperficiallayercellsandinhibitingsynovitis
AT shuhuayang multipleumbilicalcordderivedmscsadministrationsattenuateratosteoarthritisprogressionviapreservingarticularcartilagesuperficiallayercellsandinhibitingsynovitis
AT dongchengwu multipleumbilicalcordderivedmscsadministrationsattenuateratosteoarthritisprogressionviapreservingarticularcartilagesuperficiallayercellsandinhibitingsynovitis
AT xiaomingsheng multipleumbilicalcordderivedmscsadministrationsattenuateratosteoarthritisprogressionviapreservingarticularcartilagesuperficiallayercellsandinhibitingsynovitis
AT yingzezhang multipleumbilicalcordderivedmscsadministrationsattenuateratosteoarthritisprogressionviapreservingarticularcartilagesuperficiallayercellsandinhibitingsynovitis
AT hongtaotian multipleumbilicalcordderivedmscsadministrationsattenuateratosteoarthritisprogressionviapreservingarticularcartilagesuperficiallayercellsandinhibitingsynovitis